Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TNDM stock hub

Tandem Diabetes Care, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TNDMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TNDM

In the news

Latest news · TNDM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-65.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-20.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TNDM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001438133
Company name	Tandem Diabetes Care, Inc.
Country	United States
Country code	US
Cusip	875372203
Employees	2,500
Employees Change	-150%
Employees Change Percent	-5.66
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2013-11-14
Isin	US8753722037
Last refreshed	2026-05-10
Market cap	$1.1B
Market cap category	Small-Cap
Price	$15.48
Price currency	USD
Rev Per Employee	411,014x
Sector	Healthcare
Sic	3841
Symbol	TNDM
Website	https://www.tandemdiabetes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.91%
EV Sales Forward	1.12x
EV/Sales	1.19x
FCF yield	-0.34%
P/B ratio	8.01x
P/S ratio	1.03x
PS Forward	0.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.94%
EBITDA Margin	-4.2%
Gross margin	54.93%
Gross Profit	$564.4M
Gross Profit Growth	9.95%
Gross Profit Growth Q	15.52%
Gross Profit Growth3 Y	11.72%
Gross Profit Growth5 Y	14.76%
Net Income	$-94.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-9.54%
Profit Margin	-9.2%
Profit Per Employee	$-37,819
ROA	-3.68
Roa5y	-4.54
ROCE	-6.74
ROE	-65.73
Roe5y	-41.61
ROIC	-20.06
Roic5y	-25.83

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-14.54%
Cagr1y	-30.48%
Cagr3y	-23.85%
Cagr5y	-28.73%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	40.65%
OCF Growth3 Y	2.26%
OCF Growth5 Y	-23.32%
Revenue Growth	4.54x
Revenue Growth Q	5.46x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	8.94x
Revenue Growth5 Y	13.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.99
Assets	$1.2B
Cash	$570.3M
Current Assets	$887.1M
Current Liabilities	$248M
Debt	$734.7M
Debt Equity	$5.55
Equity	$132.4M
Interest Coverage	-7.4
Liabilities	$1B
Long Term Assets	$266.3M
Long Term Liabilities	$773M
Net Cash	$-164.5M
Net Cash By Market Cap	$-15.5
Net Debt Equity	$1.24
Tangible Book Value	$132.4M
Tangible Book Value Per Share	$1.93
WACC	8.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.58
Inventory Turnover	3.46
Net Working Capital	$89M
Quick ratio	2.87
Working Capital	$639.1M
Working Capital Turnover	$2.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.14%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-79.22%
1Y total return	-30.46%
200-day SMA	18.09
3Y total return	-55.85%
50-day SMA	21.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-81.6%
All Time High	302.5
All Time High Change	-94.88%
All Time High Date	2014-01-14
All Time Low	2.14
All Time Low Change	623.36%
All Time Low Date	2018-02-09
ATR	1.5
Beta	1.64
Beta1y	-0.05
Beta2y	0.86
Ch YTD	-29.57
High	20.03
High52	29.65
High52 Date	2026-02-24
High52ch	-47.79%
Low	15.44
Low52	9.98
Low52 Date	2025-08-07
Low52ch	55.11%
Ma50ch	-26.32%
Premarket Change Percent	9.31
Premarket Price	$20.19
Premarket Volume	20,287
Price vs 200-day SMA	-14.42%
RSI	31.39
RSI Monthly	41.13
RSI Weekly	39.47
Sharpe ratio	-0.16x
Sortino ratio	-0.18
Total Return	-3.14%
Tr YTD	-29.57
Tr1m	-15.32%
Tr1w	-20.29%
Tr3m	-19.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	19
Analyst Count Top	3
Analyst Price Target Top	$24.67
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.45
Earnings Revenue Estimate	240,218,960x
Earnings Revenue Estimate Growth	2.47x
Operating Income	$-61.1M
Operating margin	-5.94
Price target	$28
Price Target Change	$80.88
Price Target Change Top	$59.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,785,161%
Float Percent	91.62%
Net Borrowing	259,240,000
Shares Insiders	1.05%
Shares Institutions	107.78%
Shares Out	68,529,089
Shares Qo Q	0.56%
Shares Yo Y	3.14%
Short Float	15.36%
Short Ratio	5.25
Short Shares	14.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-86.2M
Average Volume	2,060,453.15x
Bv Per Share	1.93
CAPEX	$-23.3M
Ch10y	-79.22
Ch1m	-15.32
Ch1w	-20.29
Ch1y	-30.46
Ch3m	-19.25
Ch3y	-55.85
Ch5y	-81.6
Ch6m	-4.8
Change	-16.19%
Change From Open	-22.6
Close	18.47
Days Gap	8.28
Depreciation Amortization	17,859,000
Dollar Volume	116,604,044.3
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-61.1M
EBITDA	$-43.2M
EPS	$-1.39
F Score	4
FCF	$-3.6M
FCF EV Yield	-0.3x
FCF Per Share	$-0.05
Financing CF	235,482,000
Fiscal Year End	December
Founded	2,006
Income Tax	$-3.5M
Investing CF	-131,758,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2017-10-10
Last Split Type	Reverse
Last10k Filing Date	2026-02-19
Ma150	19.87
Ma150ch	-22.09%
Ma20	19.62
Ma20ch	-21.12%
Net CF	125,751,000
Next Earnings Date	2026-08-05
Open	20
Optionable	Yes
P OCF Ratio	54.09
Position In Range	0.87
Post Close	15.48
Postmarket Change Percent	0.71
Postmarket Price	$15.59
Ppne	178,990,000
Pre Close	18.47
Price Date	2026-05-08
Ptbv Ratio	8.01
Relative Volume	3.66x
Revenue	1,027,535,000x
SBC By Revenue	8.03x
Share Based Comp	82,552,000
Tax By Revenue	-0.34x
Tr6m	-4.8%
Us State	California
Volume	7,532,561
Z Score	0.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TNDM pay a dividend?

Capital-return profile for this ticker.

Performance

TNDM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TNDM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+107.8%

Float: +91.6% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TNDM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.4

Neutral momentum band

Price vs 200-day MA

-14.4%

50/200-day relationship not available

Beta (5Y)

1.64

More volatile than the market

Sharpe ratio

-0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TNDM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TNDM stock rating?

Tandem Diabetes Care, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TNDM analysis?

The full report lives at /stocks/TNDM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TNDM?

The latest report frames TNDM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TNDM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.